For citations:

Vakhitova A.A., Orlova R.V. Inhibitors of cyclin-dependent kinases as new class of drugs in oncology. Achievements and development prospects in treatment of ER+ /HER 2- breast cancer. Medical alphabet. 2019;1(10):6-14. (In Russ.) https://doi.org/10.33667/2078-5631-2019-1-10(385)-6-14